logo
logo

Verdesian Life Sciences Announces Investment from AEA Investors

Jan 19, 2021•over 4 years ago
Cary

Description

Verdesian Life Sciences ("Verdesian" or the "Company"), a leading platform that develops patented biological, nutritional, fertilizer enhancers, seed treatment and inoculant technologies for high-value specialty crops, row crops, and turf and ornamental markets, today announced it has entered into a definitive stock purchase agreement with funds managed by AEA Investors LP ("AEA"). Verdesian's management team, including President and CEO Kenny Avery, will continue to lead the Company following the close of the transaction.

Company Information

Company

Verdesian

Location

Cary, Illinois, United States

About

Founded in 2012, Verdesian Life Sciences offers patented biological, nutritional, fertilizer enhancers, seed treatment and inoculant technologies for high-value specialty crops, row crops, and turf and ornamental markets. Verdesian's plant-health products, nutritional catalysts and seed treatments/inoculants help growers farm more efficiently to maximize yields. Verdesian's technologies answer the needs facing agriculture including increasing pressures on food demand, supply and food safety. Verdesian remains committed to the research and development of environmentally sustainable products. Further information about Verdesian is available at www.vlsci.com.

Related People